Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 7686045, 12 pages
http://dx.doi.org/10.1155/2016/7686045
Research Article

Effects of Active Components of Fuzi and Gancao Compatibility on Bax, Bcl-2, and Caspase-3 in Chronic Heart Failure Rats

Zhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang 310053, China

Received 4 July 2016; Revised 2 October 2016; Accepted 9 October 2016

Academic Editor: Giuseppe Caminiti

Copyright © 2016 Liqin Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Zhou, L. Tang, X. Zhou, T. Wang, Z. Kou, and Z. Wang, “A review on phytochemistry and pharmacological activities of the processed lateral root of Aconitum carmichaelii Debeaux,” Journal of Ethnopharmacology, vol. 160, pp. 173–193, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-M. Zhang, W. Liao, Y.-X. He, Y. He, D. Yan, and C.-M. Fu, “Study on intestinal absorption and pharmacokinetic characterization of diester diterpenoid alkaloids in precipitation derived from Fuzi-Gancao herb-pair decoction for its potential interaction mechanism investigation,” Journal of Ethnopharmacology, vol. 147, no. 1, pp. 128–135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Zhang, Y. Song, Q. Song et al., “Qualitative and quantitative assessments of Aconiti lateralis radix praeparata using high-performance liquid chromatography coupled with diode array detection and hybrid ion trap-time-of-flight mass spectrometry,” Journal of Chromatographic Science, vol. 54, no. 6, pp. 888–901, 2016. View at Google Scholar
  4. X. Liu, H. Li, X. Song et al., “Comparative pharmacokinetics studies of benzoylhypaconine, benzoylmesaconine, benzoylaconine and hypaconitine in rats by LC-MS method after administration of Radix Aconiti Lateralis Praeparata extract and Dahuang Fuzi Decoction,” Biomedical Chromatography, vol. 28, no. 7, pp. 966–973, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Fan, N. Li, H. Xu, J. Xiang, L. Wang, and Y. Gao, “The mechanism of hydrothermal hydrolysis for glycyrrhizic acid into glycyrrhetinic acid and glycyrrhetinic acid 3-O-mono-β-d-glucuronide in subcritical water,” Food Chemistry, vol. 190, pp. 912–921, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Rauchensteiner, Y. Matsumura, Y. Yamamoto, S. Yamaji, and T. Tani, “Analysis and comparison of Radix Glycyrrhizae (licorice) from Europe and China by capillary-zone electrophoresis (CZE),” Journal of Pharmaceutical and Biomedical Analysis, vol. 38, no. 4, pp. 594–600, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Sun, M. Zhang, Q. Zhang et al., “Metabonomics study of the effects of pretreatment with glycyrrhetinic acid on mesaconitine-induced toxicity in rats,” Journal of Ethnopharmacology, vol. 154, no. 3, pp. 839–846, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. C.-H. Xu, P. Wang, Y. Wang et al., “Pharmacokinetic comparisons of two different combinations of Shaoyao-Gancao Decoction in rats: Competing mechanisms between paeoniflorin and glycyrrhetinic acid,” Journal of Ethnopharmacology, vol. 149, no. 2, pp. 443–452, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Wang, L. Shi, X. Tang, Q. Wang, X. Dang, and Y. Zhang, “Pharmacokinetic study of multiple active constituents from Kushen-Gancao Decoction after oral administration in rat by HPLC-MS/MS,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 965, pp. 19–26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. Q.-T. Gao, X.-H. Chen, and K.-S. Bi, “Comparative pharmacokinetic behavior of glycyrrhetic acid after oral administration of glycyrrhizic acid and Gancao-Fuzi-Tang,” Biological and Pharmaceutical Bulletin, vol. 27, no. 2, pp. 226–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Zhu, G. Zhang, M. Wang, J. Wang, W. Zeng, and X. Gao, “Simultaneous determination of nine active compounds of the traditional Chinese medicinal prescription Shaoyao-Gancao-Tang and analysis of the relationship between therapeutical effect and compatibility of medicines,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 521038, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. C. deAlmeida, R. J. van Oort, and X. H. T. Wehrens, “Transverse aortic constriction in mice,” Journal of Visualized Experiments: JoVE, no. 38, article 1729, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. J. LaRocca, D. Jeong, E. Kohlbrenner et al., “CXCR4 gene transfer prevents pressure overload induced heart failure,” Journal of Molecular and Cellular Cardiology, vol. 53, no. 2, pp. 223–232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. P.-P. Xing, W.-H. Wu, P. Du, F.-M. Han, and Y. Chen, “Effects of brucine combined with glycyrrhetinic acid or liquiritin on rat hepatic cytochrome P450 activities in vivo,” Acta Pharmaceutica Sinica, vol. 46, no. 5, pp. 573–580, 2011. View at Google Scholar · View at Scopus
  15. W. Peng, M. J. Yi, J. J. Wang et al., “Effects of hypaconitine combined with liquiritin on the mRNA expression of ion channel genes related with cardiac muscle excitation-contraction coupling,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 28, no. 1, pp. 117–120, 2013 (Chinese). View at Google Scholar
  16. Y. Z. Zou, L. Lin, Y. Ye et al., “Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice,” Journal of Cardiovascular Pharmacology, vol. 59, no. 3, pp. 268–280, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-J. Lin, Y.-S. Chang, L.-H. Lin, C.-F. Haung, C.-Y. Wu, and K.-L. Ou, “An immunomodulatory protein (Ling Zhi-8) from a Ganoderma lucidum induced acceleration of wound healing in rat liver tissues after monopolar electrosurgery,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 916531, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Redfield, S. J. Jacobsen, J. C. Burnett Jr., D. W. Mahoney, K. R. Bailey, and R. J. Rodeheffer, “Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic,” Journal of the American Medical Association, vol. 289, no. 2, pp. 194–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Bui, T. B. Horwich, and G. C. Fonarow, “Epidemiology and risk profile of heart failure,” Nature Reviews Cardiology, vol. 8, no. 1, pp. 30–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Yach, C. Hawkes, C. L. Gould, and K. J. Hofman, “The global burden of chronic diseases: overcoming impediments to prevention and control,” The Journal of the American Medical Association, vol. 291, no. 21, pp. 2616–2622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Levy, S. Kenchaiah, M. G. Larson et al., “Long-term trends in the incidence of and survival with heart failure,” The New England Journal of Medicine, vol. 347, no. 18, pp. 1397–1402, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Bonneux, J. J. Barendregt, K. Meeter, G. J. Bonsel, and P. J. Van der Maas, “Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure,” American Journal of Public Health, vol. 84, no. 1, pp. 20–28, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Yu, J. Zhang, H. Liu, B. Liu, and L. Meng, “Identification of nondiabetic heart failure-associated genes by bioinformatics approaches in patients with dilated ischemic cardiomyopathy,” Experimental and Therapeutic Medicine, vol. 11, no. 6, pp. 2602–2608, 2016. View at Google Scholar
  24. P. M. Kang and S. Izumo, “Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases,” Trends in Molecular Medicine, vol. 9, no. 4, pp. 177–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Shimizu and T. Minamino, “Physiological and pathological cardiac hypertrophy,” Journal of Molecular and Cellular Cardiology, vol. 97, pp. 245–262, 2016. View at Publisher · View at Google Scholar
  26. Z. G. Ma, J. Dai, W. Y. Wei et al., “Asiatic acid protects against cardiac hypertrophy through activating AMPKα signalling pathway,” International Journal of Biological Sciences, vol. 12, no. 7, pp. 861–871, 2016. View at Publisher · View at Google Scholar
  27. H. Wei, H. Wu, W. Yu, X. Yan, and X. Zhang, “Shenfu decoction as adjuvant therapy for improving quality of life and hepatic dysfunction in patients with symptomatic chronic heart failure,” Journal of Ethnopharmacology, vol. 169, pp. 347–355, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. A. E. Khodir, H. A. Ghoneim, M. A. Rahim, and G. Suddek, “Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats,” Human & Experimental Toxicology, vol. 35, no. 4, pp. 388–397, 2016. View at Publisher · View at Google Scholar
  29. P. Ponikowski, A. A. Voors, S. D. Anker et al., “2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC,” European Heart Journal, vol. 37, no. 27, pp. 2129–2200, 2016. View at Publisher · View at Google Scholar
  30. R. Laszlo, T. Baumann, H. Konz et al., “Right ventricular function assessed by tissue Doppler echocardiography in older subjects without evidence for structural cardiac disease,” Aging Clinical and Experimental Research, 2016. View at Publisher · View at Google Scholar
  31. M. Evran, G. Akkuş, İ. Berk Bozdoğan et al., “Carotid intima-media thickness as the cardiometabolic risk indicator in patients with nonfunctional adrenal mass and metabolic syndrome screening,” Medical Science Monitor, vol. 22, pp. 991–997, 2016. View at Publisher · View at Google Scholar
  32. P. Jarolim, P. P. Patel, M. J. Conrad, L. Chang, V. Melenovsky, and D. H. Wilson, “Fully automated ultrasensitive digital immunoassay for cardiac troponin i based on single molecule array technology,” Clinical Chemistry, vol. 61, no. 10, pp. 1283–1291, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Cheng, W. Z. Fan, S. C. Wang et al., “Prognostic utility of combination of NT-proBNP with high sensitive cTn I in patients with heart failure: results from retrospective study in an emergency department,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 76, no. 5, pp. 361–367, 2016. View at Publisher · View at Google Scholar
  34. A. Joharimoghadam, M. Tajdini, and A. Bozorgi, “Salivary B-type natriuretic peptide: a new method for heart failure diagnosis and follow up,” Kardiologia Polska, 2016. View at Publisher · View at Google Scholar
  35. M. Oremus, A. Don-Wauchope, R. McKelvie et al., “BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure,” Heart Failure Reviews, vol. 19, no. 4, pp. 471–505, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. R. S. Wong, “Apoptosis in cancer: from pathogenesis to treatment,” Journal of Experimental and Clinical Cancer Research, vol. 30, no. 1, article 87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. S. Davids and A. Letai, “Targeting the B-cell lymphoma/leukemia 2 family in cancer,” Journal of Clinical Oncology, vol. 30, no. 25, pp. 3127–3135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Tomek, T. Akiyama, and C. R. Dass, “Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy,” The Journal of Pharmacy and Pharmacology, vol. 64, no. 12, pp. 1695–1702, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Leibowitz and J. Yu, “Mitochondrial signaling in cell death via the Bcl-2 family,” Cancer Biology & Therapy, vol. 9, no. 6, pp. 417–422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Maulik, R. M. Engelman, J. A. Rousou, J. E. Flack III, D. Deaton, and D. K. Das, “Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2,” Circulation, vol. 100, no. 19, pp. II369–II375, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Malla, S. Gopinath, K. Alapati et al., “Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas,” PLoS ONE, vol. 5, no. 10, Article ID e13731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Zhao, J. Li, W. Li et al., “Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing,” British Journal of Pharmacology, vol. 159, no. 8, pp. 1584–1594, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Bartling, H. Milting, H. Schumann et al., “Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure,” Circulation, vol. 100, no. 19, pp. II216–II223, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. R. A. de Boer, D. J. van Veldhuisen, J. van der Wijk et al., “Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure,” Journal of Cardiac Failure, vol. 6, no. 4, pp. 330–337, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. K.-L. Laugwitz, A. Schömig, M. Ungerer et al., “Blocking caspase-activated apoptosis improves contractility in failing myocardium,” Human Gene Therapy, vol. 12, no. 17, pp. 2051–2063, 2001. View at Publisher · View at Google Scholar · View at Scopus